BNGO logo

BNGO
Bionano Genomics Inc

100,679
Mkt Cap
$13.2M
Volume
546.00
52W High
$5.50
52W Low
$1.06
PE Ratio
-0.23
BNGO Fundamentals
Price
$1.16
Prev Close
$1.15
Open
$1.17
50D MA
$1.20
Beta
1.65
Avg. Volume
121,356.57
EPS (Annual)
-$4.85
P/B
0.35
Rev/Employee
$293,896.91
$4.31
Loading...
Loading...
News
all
press releases
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Bionano Genomics (BNGO) delivered earnings and revenue surprises of +6.17% and +2.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6d ago
News Placeholder
More News
News Placeholder
Arvinas, Inc. (ARVN) Reports Q1 Loss, Misses Revenue Estimates
Arvinas (ARVN) delivered earnings and revenue surprises of +5.01% and -0.74%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
Lexicon Pharmaceuticals (LXRX) Reports Break-Even Earnings for Q1
Lexicon (LXRX) delivered earnings and revenue surprises of +100.00% and +141.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
Bionano Genomics (BNGO) Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·2mo ago
News Placeholder
Bionano Genomics Stock Soars As Efficiency Gains Meet Growth Story
Bionano Genomics stock soared on Monday as investors anticipated the company's Q4 earnings report.read more...
Benzinga·2mo ago
News Placeholder
United Airlines, AGI And 3 Stocks To Watch Heading Into Monday
US stock futures down, Caledonia Mining, United Airlines & Agi to report earnings, Cheetah Net & BioNano Genomics to release results.read more...
Benzinga·2mo ago
News Placeholder
Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Bionano Genomics, Inc. (BNGO) will release Q4 earnings on March 23. Analysts expect $1.40 loss per share on $7.85M revenue. Stock closed at $1.12.read more...
Benzinga·2mo ago
News Placeholder
Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?
Here is how Black Diamond (BDTX) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.
Zacks·4mo ago
News Placeholder
iBio, Inc. (IBIO) Reports Q1 Loss
iBio (IBIO) delivered earnings and revenue surprises of -57.14% and 0.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6mo ago
News Placeholder
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates
Keros Therapeutics (KROS) delivered earnings and revenue surprises of +83.78% and +86.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6mo ago
<
1
2
...
>

Latest BNGO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.